ALSO. . .

* Deutsche Boerse’s planned merger with the London Stock Exchange appeared closer to derailment during the weekend, with a crucial vote on the project now likely to be postponed, sources told Reuters. The German bourse operator’s supervisory board, which meets today, is widely expected to delay a Thursday shareholder vote to approve the deal. The deal has come under mounting pressure since Swedish bourse operator OM Group launched a hostile bid for the LSE last month.

* Glaxo Wellcome and SmithKline Beecham face a nail-biting week with U.S. antitrust approval for their mega-merger needed by Wednesday if completion is not to be postponed a second time.